Howes, Oliver D.
Cummings, Connor http://orcid.org/0000-0002-9940-0092
Chapman, George E.
Shatalina, Ekaterina
Article History
Received: 25 April 2022
Revised: 3 August 2022
Accepted: 5 August 2022
First Online: 2 September 2022
Competing interests
: OH is a part-time employee of H Lundbeck A/s. He has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan. Neither Dr Howes or his family have holdings/a financial stake in any pharmaceutical company. Dr Howes has a patent for the use of dopaminergic imaging. ES, GC and CC have reported no biomedical financial interests or potential conflicts of interest. The views expressed are those of the authors and not necessarily those of H Lundbeck A/s, the NHS/NIHR or the Department of Health.